Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

被引：0
|
作者：
Tjalf Ziemssen
Michael Lang
Stephan Schmidt
Holger Albrecht
Luisa Klotz
Judith Haas
Christoph Lassek
Stefan Lang
Veronika E. Winkelmann
Benjamin Ettle
Ulf Schulze-Topphoff
机构：
[1] University of Technology,Center of Clinical Neuroscience, Neurological University Clinic Carl Gustav Carus
[2] NeuroPoint Patient Academy and Neurological Practice,Department of Neurology
[3] Health Center St. Johannes,Center for Multiple Sclerosis
[4] Neurological Practice,undefined
[5] University Hospital Münster,undefined
[6] Jewish Hospital Berlin,undefined
[7] Neurological Practice,undefined
[8] Kassel and Vellmar,undefined
[9] Scientific and Medical Writing,undefined
[10] Novartis Pharma GmbH,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Relapsing–remitting multiple sclerosis; Fingolimod; Real-world; Safety; Effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3276 / 3285
页数：9
相关论文
共 50 条
  • [1] Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
    Ziemssen, Tjalf
    Lang, Michael
    Schmidt, Stephan
    Albrecht, Holger
    Klotz, Luisa
    Haas, Judith
    Lassek, Christoph
    Lang, Stefan
    Winkelmann, Veronika E.
    Ettle, Benjamin
    Schulze-Topphoff, Ulf
    JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3276 - 3285
  • [2] Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
    Druart, Charlotte
    El Sankari, Souraya
    van Pesch, Vincent
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 1 - 10
  • [3] Long-Term Effectiveness of Fingolimod for Multiple Sclerosis in a Real-World Clinical Setting
    Uzunkopru, Cihat
    Beckmann, Yesim
    Ture, Sabiha
    EUROPEAN NEUROLOGY, 2021, 84 (03) : 200 - 205
  • [4] Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
    Mazzotta, Marco
    Krasniqi, Eriseld
    Barchiesi, Giacomo
    Pizzuti, Laura
    Tomao, Federica
    Barba, Maddalena
    Vici, Patrizia
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [5] 4 years PANGAEA: long-term data on effectiveness and safety from patients on natalizumab switching to fingolimod in real world
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 416 - 416
  • [6] Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
    Caroline Papeix
    Giovanni Castelnovo
    Emmanuelle Leray
    Marc Coustans
    Pierre Levy
    Jean-Marc Visy
    Gisela Kobelt
    Fabienne Lamy
    Bashar Allaf
    François Heintzmann
    Isabelle Chouette
    Eric Raponi
    Barbara Durand
    Emmanuelle Grevat
    Driss Kamar
    Marc Debouverie
    Christine Lebrun-Frenay
    Neurology and Therapy, 2022, 11 : 633 - 658
  • [7] Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
    Papeix, Caroline
    Castelnovo, Giovanni
    Leray, Emmanuelle
    Coustans, Marc
    Levy, Pierre
    Visy, Jean-Marc
    Kobelt, Gisela
    Lamy, Fabienne
    Allaf, Bashar
    Heintzmann, Francois
    Chouette, Isabelle
    Raponi, Eric
    Durand, Barbara
    Grevat, Emmanuelle
    Kamar, Driss
    Debouverie, Marc
    Lebrun-Frenay, Christine
    NEUROLOGY AND THERAPY, 2022, 11 (02) : 633 - 658
  • [8] 4 Years PANGAEA: Long Term Data on Effectiveness and Safety from Patients on Natalizumab Switching to Fingolimod in Real World
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2016, 86
  • [9] Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder
    Lintunen, Jonne
    Taipale, Heidi
    Tanskanen, Antti
    Mittendorfer-Rutz, Ellenor
    Tiihonen, Jari
    Lahteenvuo, Markku
    SCHIZOPHRENIA BULLETIN, 2021, 47 (04) : 1099 - 1107
  • [10] Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
    Chaparro, Maria
    Acosta, Diana
    Rodriguez, Cristina
    Mesonero, Francisco
    Vicuna, Miren
    Barreiro-de Acosta, Manuel
    Fernandez-Clotet, Agnes
    Martinez, Alvaro Hernandez
    Arroyo, Maite
    Vera, Isabel
    Ruiz-Cerulla, Alexandra
    Sicilia, Beatriz
    Tapia, M. Jose Cabello
    Villafranca, Carmen Munoz
    Castro-Poceiro, Jesus
    Cadilla, Jesus Martinez
    Sierra-Ausin, Monica
    Moron, Juan Maria Vazquez
    Lidon, Raquel Vicente
    Bermejo, Fernando
    Royo, Vanesa
    Calafat, Margalida
    Gonzalez-Munoza, Carlos
    Carnerero, Eduardo Leo
    Marcos, Noemi Mancenido
    Torrealba, Leyanira
    Alonso-Galan, Horacio
    Benitez, Jose Manuel
    Nieto, Yolanda Ber
    Palomares, M. Teresa Diz-Lois
    Garcia, Maria Jose
    Munoz, Jose Fernando
    Gonzalez, Edisa Maria Armesto
    Calvet, Xavier
    Hernandez-Camba, Alejandro
    Dominguez, Rosa Eva Madrigal
    Menchen, Luis
    Calle, Jose Lazaro Perez
    Piqueras, Marta
    Sadornil, Carmen Duenas
    Botella, Belen
    Martinez-Perez, Teresa de Jesus
    Ramos, Laura
    Rodriguez-Grau, Maria Carmen
    San Miguel, Elena
    Forcelledo, Jose Luis Fernandez
    Salazar, Paola Maria Fradejas
    Garcia-Sepulcre, Marife
    Gutierrez, Ana
    Llao, Jordina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (07): : 1237 - 1247
12345